The latest price target for TuHURA Biosciences (NASDAQ:HURA) was reported by Rodman & Renshaw on December 19, 2024. The analyst firm set a price target for $11.00 expecting HURA to rise to within 12 months (a possible 150.00% upside). 1 analyst firms have reported ratings in the last year.

The latest analyst rating for TuHURA Biosciences (NASDAQ:HURA) was provided by Rodman & Renshaw, and TuHURA Biosciences initiated their buy rating.

There is no last upgrade for TuHURA Biosciences

There is no last downgrade for TuHURA Biosciences.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of TuHURA Biosciences, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for TuHURA Biosciences was filed on December 19, 2024 so you should expect the next rating to be made available sometime around December 19, 2025.

While ratings are subjective and will change, the latest TuHURA Biosciences (HURA) rating was a initiated with a price target of $0.00 to $11.00. The current price TuHURA Biosciences (HURA) is trading at is $4.40, which is within the analyst’s predicted range.